Glenmark Pharmaceuticals has declared its April-June quarter financial results for the fiscal year 2010-11. The pharma company has announced that it has registered an impressive three fold net profit rise in the quarter under review.

Glenmark Pharmaceuticals has reported that a net profit of Rs 155.54 crore for the quarter that ended in 30th June, 2010 which is almost three fold of the net profit figure of the similar quarter in the last fiscal. The company has registered a net profit of Rs 53.4 crore in the same quarter that ended in 30th June in the previous year.

Glenmark Pharmaceuticals has informed this in a filing at the Bombay Stock Exchange. As per company officials the huge growth in the goods sales of the company is the major factor of such net profit hike.

The total income of the company was reported to be Rs 707.9 crore during the April-June quarter of fiscal year 2010-11. It was found out to be Rs 551.2 crore for the same quarter in the preceding year.